Trademark: 88226880
Status Date
Monday, August 22, 2022
Filing Date
Wednesday, December 12, 2018
Published for Opposition
Tuesday, May 21, 2019
Abandoned Date
Monday, August 22, 2022
5 Pharmaceutical preparations and substances for the treatment of pain, cardiovascular disorders, alimentary tract and metabolism problems, respiratory diseases, endocrine, musculoskeletal, cardiopulmonary, genitourinary, oncological, hepatological, ophthalmological, otologicals, neurological, gastrointestinal, hormonal, dermatological and psychiatric related diseases and disorders and for the treatment of damaged skin and tissue; anti-inflammatory and anti-rheumatics drugs; pharmaceutical preparations, namely, immunomodulators; pharmaceutical preparations, namely, hematological agents being pharmaceuticals for the treatment of hematological diseases; Enzyme replacement therapy preparations; Enzyme replacement therapy products, namely, infusions, liquids, tablets and powders for human use in the treatment of genetic disorders for medical purposes; Therapeutic cellular and stem cell compositions for medical use
The wording "OLBRICEN" has no meaning in a foreign language.
Aug 22, 2022
Abandonment Notice E-Mailed - No Use Statement Filed
Aug 22, 2022
Abandonment - No Use Statement Filed
Jan 4, 2022
Notice Of Approval Of Extension Request E-Mailed
Jan 3, 2022
Sou Extension 5 Granted
Dec 17, 2021
Sou Extension 5 Filed
Dec 28, 2021
Case Assigned To Intent To Use Paralegal
Dec 17, 2021
Sou Teas Extension Received
Jul 9, 2021
Notice Of Approval Of Extension Request E-Mailed
Jul 7, 2021
Sou Extension 4 Granted
Jul 7, 2021
Sou Extension 4 Filed
Jul 7, 2021
Sou Teas Extension Received
Dec 18, 2020
Notice Of Approval Of Extension Request E-Mailed
Dec 16, 2020
Sou Extension 3 Granted
Dec 16, 2020
Sou Extension 3 Filed
Dec 16, 2020
Sou Teas Extension Received
Jul 4, 2020
Notice Of Approval Of Extension Request E-Mailed
Jul 2, 2020
Sou Extension 2 Granted
Jul 2, 2020
Sou Extension 2 Filed
Jul 2, 2020
Sou Teas Extension Received
Dec 11, 2019
Notice Of Approval Of Extension Request E-Mailed
Dec 9, 2019
Sou Extension 1 Granted
Dec 9, 2019
Sou Extension 1 Filed
Dec 9, 2019
Sou Teas Extension Received
Jul 16, 2019
Noa E-Mailed - Sou Required From Applicant
May 21, 2019
Official Gazette Publication Confirmation E-Mailed
May 21, 2019
Published For Opposition
May 1, 2019
Notification Of Notice Of Publication E-Mailed
Apr 12, 2019
Assigned To Lie
Mar 22, 2019
Approved For Pub - Principal Register
Mar 15, 2019
Examiner's Amendment Entered
Mar 15, 2019
Notification Of Examiners Amendment E-Mailed
Mar 15, 2019
Examiners Amendment E-Mailed
Mar 15, 2019
Examiners Amendment -Written
Mar 11, 2019
Assigned To Examiner
Jan 4, 2019
New Application Office Supplied Data Entered
Dec 15, 2018
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
